Diagnosis and Management of Paget’s Disease of Bone in Adults: A Clinical Guideline
The effects of denosumab and alendronate on osteoporosis in hemodialysis patients
Exercise for preventing falls in older people living in the community
A novel interplay between irisin & PTH: from basic studies to clinical evidence in hyperparathyroidism
Invasive Oral Procedures and Events in Women With Postmenopausal Osteoporosis Treated With Denosumab for up to 10 Years
Hypercalcitoninaemia in pseudohypoparathyroidism type 1A and type 1B
Is It Time to Stop (or Pause) Vertebral Augmentation?
The Efficacy & Safety of Vertebral Augmentation: Second ASBMR Task Force Report
GOOD NEWS FOR ROMOSOZUMAB
An FDA advisory panel on Wednesday voted 18-1 that the benefits of Amgen and UCB's monthly injection Evenity (romosozumab) outweigh its risks for the treatment of osteoporosis in postmenopausal women at high risk for fracture.
Serum 25-hydroxyvitamin D status, quantitative ultrasound parameters, and their determinants in Greek population
ΑΡΘΡΟ: ΜΕΤΑ-ΑΝΑΛΥΣΗ & ΒΙΤΑΜΙΝΗ D
FRAX:Greek intervention thresholds
ΑΡΘΡΟ: ΖΟΛΕΔΡΟΝΙΚΟ ΟΞΥ & ΟΣΤΕΟΠΕΝΙΑ
Management of Chronic Kidney Disease
Association Between Hyponatremia, Osteoporosis and Fracture: a Systematic Review and Meta-analysis